Frank O. Nestle, M.D. FMedSci is currently Global Head of Research and Chief Scientific Officer at Sanofi with responsibility for Sanofi’s main therapeutic research areas of Immunology & Inflammation, Oncology including Immuno-Oncology, Neurology, Rare Diseases, Hematology and Genomic Medicine with a mandate to innovate and accelerate first and best in class medicines from discovery to clinical translation.
Frank joined Sanofi in 2016 as founding Therapeutic Area Head for Immunology & Inflammation Research where he established the current organizational structure, recruited a cadre of leading immune-scientists and built a portfolio of first and best in class clinical candidate molecules with 15 immunology new molecular entities currently in clinical Development.
Before joining Sanofi, Frank was a Professor and Chair of Cutaneous Medicine and Immunotherapy at King’s College London (United Kingdom) and practiced medicine at Guy’s and St. Thomas’ Hospital, a leading UK University Hospital, where he was also a member of the Board of Directors. At King’s College, Frank led research, translational clinical trials, and teams in Dermatology, Allergology and Immunology. In addition, he held several executive roles, in particular at the Guy’s and St Thomas’ Biomedical Research Center. He built the Clinical Research Facilities and led the Biomarker and Co-Diagnostics Cluster overseeing cross-disease area precision medicine projects and translational research platforms including Genomics, Flow Cytometry, Translational Bioinformatics and Bioresource.
Frank is a Fellow of the Academy of Medical Sciences, a Senior Investigator Emeritus at the National Institute for Health Research (NIHR) and Past-President of the Federation of Clinical Immunology Societies (FOCIS).
Frank has published over 220 scientific articles (H index 82; > 32000 citations) in publications such as Nature, Nature Medicine, Cell, New England Journal of Medicine and has received several awards and honors, including the Alfred Marchionini Research Award at the 20th World Congress of Dermatology.
Frank joined Sanofi in 2016 as founding Therapeutic Area Head for Immunology & Inflammation Research where he established the current organizational structure, recruited a cadre of leading immune-scientists and built a portfolio of first and best in class clinical candidate molecules with 15 immunology new molecular entities currently in clinical Development.
Before joining Sanofi, Frank was a Professor and Chair of Cutaneous Medicine and Immunotherapy at King’s College London (United Kingdom) and practiced medicine at Guy’s and St. Thomas’ Hospital, a leading UK University Hospital, where he was also a member of the Board of Directors. At King’s College, Frank led research, translational clinical trials, and teams in Dermatology, Allergology and Immunology. In addition, he held several executive roles, in particular at the Guy’s and St Thomas’ Biomedical Research Center. He built the Clinical Research Facilities and led the Biomarker and Co-Diagnostics Cluster overseeing cross-disease area precision medicine projects and translational research platforms including Genomics, Flow Cytometry, Translational Bioinformatics and Bioresource.
Frank is a Fellow of the Academy of Medical Sciences, a Senior Investigator Emeritus at the National Institute for Health Research (NIHR) and Past-President of the Federation of Clinical Immunology Societies (FOCIS).
Frank has published over 220 scientific articles (H index 82; > 32000 citations) in publications such as Nature, Nature Medicine, Cell, New England Journal of Medicine and has received several awards and honors, including the Alfred Marchionini Research Award at the 20th World Congress of Dermatology.
Speaking In
1:45 PM - 2:45 PM
Tuesday, June 6
